# Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome

> **NCT02000960** · PHASE2 · UNKNOWN · sponsor: **University of British Columbia** · enrollment: 3 (estimated)

## Conditions studied

- Glucose Transporter Type 1 Deficiency Syndrome

## Interventions

- **DRUG:** Triheptanoin

## Key facts

- **NCT ID:** NCT02000960
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-04
- **Primary completion:** 2016-02
- **Final completion:** 2016-10
- **Target enrollment:** 3 (ESTIMATED)
- **Last updated:** 2016-06-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02000960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02000960, "Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02000960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*